Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMRN | Amarin Corporation Plc Sponsored ADR | 2.43% | 18.15 | 2.0% | $258.39m | |
| SHPG | Shire PLC Sponsored ADR | -1.90% | 175.59 | 0.4% | $221.25m | |
| JAZZ | Jazz Pharmaceuticals Plc | -0.60% | 142.80 | 2.2% | $105.01m | |
| PRGO | Perrigo Co. Plc | -0.38% | 63.27 | 6.8% | $104.98m | |
| ENDP | Endo International Plc | -0.31% | 12.69 | 8.9% | $64.86m | |
| GWPH | GW Pharmaceuticals PLC Sponsored ADR | 1.50% | 132.30 | 6.3% | $64.59m | |
| MNK | Mallinckrodt Plc | -1.85% | 30.85 | 21.1% | $58.56m | |
| SAGE | SAGE Therapeutics, Inc. | 2.08% | 114.21 | 9.6% | $57.88m | |
| HZNP | Horizon Pharma plc | 2.87% | 21.86 | 7.4% | $53.25m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 1.80% | 102.70 | 18.7% | $51.93m | |
| UTHR | United Therapeutics Corporation | 4.45% | 121.49 | 14.4% | $49.60m | |
| CTLT | Catalent Inc | 0.87% | 39.39 | 2.4% | $40.94m | |
| PTLA | Portola Pharmaceuticals, Inc. | -0.99% | 20.00 | 7.7% | $34.00m | |
| ICLR | ICON Plc | -1.58% | 132.87 | 4.1% | $33.59m | |
| AERI | Aerie Pharmaceuticals, Inc. | 0.33% | 42.87 | 6.9% | $29.36m |
Company Profile
SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA.